An imidazole antifungal agent
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Sertaconazole (nitrate)

Item No. 22232

Technical Information
Formal Name
1-[2-[(7-chlorobenzo[b]thien-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole, mononitrate
CAS Number
99592-39-9
Synonyms
  • FI-7045
Molecular Formula
C20H15Cl3N2OS • HNO3
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 25 mg/mlDMSO: 25 mg/mlDMSO:PBS (pH 7.2) (1:2): 0.3 mg/mlEthanol: 0.1 mg/ml
λmax
225 nm
SMILES
ClC1=CC(Cl)=CC=C1C(CN2C=NC=C2)OCC3=CSC4=C3C=CC=C4Cl.O=[N](O)=O
InChi Code
InChI=1S/C20H15Cl3N2OS.HNO3/c21-14-4-5-16(18(23)8-14)19(9-25-7-6-24-12-25)26-10-13-11-27-20-15(13)2-1-3-17(20)22;2-1(3)4/h1-8,11-12,19H,9-10H2;(H,2,3,4)
InChi Key
HAAITRDZHUANGT-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Sertaconazole is an imidazole antifungal agent.1 It is active against various yeasts, including C. albicans and C. tropicalis, and dermatophytes, including Microsporum, Trichophyton, and Epidermophyton (MICs = 0.35-5.04 and 0.24-2 µg/ml, respectively). Sertaconazole inhibits ergosterol (Item No. 19850) biosynthesis (IC50 = 115 nM) and decreases intracellular ATP levels in a concentration-dependent manner in C. albicans.2,3 Topical application of sertaconazole (1%) reduces ear edema induced by phorbol 12-myristate 13-acetate (TPA; Item No. 10008014), resiniferatoxin, or oxazolone in mouse models of irritant dermatitis, neurogenic dermatitis, and allergic contact hypersensitivity, respectively.4 Sertaconazole also selectively inhibits long-chain acyl-CoA synthetase 4 (ACSL4; IC50 = 0.28 µM) over ACSL3 at 50 µM.5 It inhibits lipid peroxidation and ferroptosis induced by (1S,3R)-RSL3 (Item No. 19288) in LUHMES cells when used at a concentration of 5 µM. Formulations containing sertaconazole have been used in the treatment of interdigital tinea pedis.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Palacin, C., Sacristán, A., and Ortiz, J.A. In vitro activity of sertaconazole. Arzneimittelforschung 42(5A), 699-705 (1992).

    2. Agut, J., Palacin, C., Salgado, J., et alDirect membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity. Arzneimittelforschung 42(5A), 721-724 (1992).

    3. Agut, J., Palacin, C., Sacristán, A., et alInhibition of ergosterol synthesis by sertaconazole in Candida albicans. Arzneimittelforschung 42(5A), 718-720 (1992).

    4. Liebel, F., Lyte, P., Garay, M., et alAnti-inflammatory and anti-itch activity of sertaconazole nitrate. Arch. Dermatol. Res. 298(4), 191-199 (2006).

    5. Marteau, R., Ravez, S., Mazhari Dorooee, D., et alRepositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis. Biochem. Pharmacol. 204, 115239 (2022).